{"nctId":"NCT03868124","briefTitle":"Clinical Study Comparing Two Models of a Travoprost Intraocular Implant","startDateStruct":{"date":"2018-09-17","type":"ACTUAL"},"conditions":["Glaucoma, Open-Angle","Ocular Hypertension"],"count":560,"armGroups":[{"label":"Implant Group 1","type":"EXPERIMENTAL","interventionNames":["Combination Product: G2-TR intraocular implant containing travoprost"]},{"label":"Implant Group 2","type":"EXPERIMENTAL","interventionNames":["Combination Product: G2-TR intraocular implant containing travoprost"]},{"label":"Control Group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sham surgery + active-comparator eye drops"]}],"interventions":[{"name":"G2-TR intraocular implant containing travoprost","otherNames":["Implant Group"]},{"name":"Sham surgery + active-comparator eye drops","otherNames":["Control Group"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosed with open-angle glaucoma or ocular hypertension\n* C/D ratio â‰¤ 0.8\n* Zero to two preoperative ocular hypotensive medications\n\nExclusion Criteria:\n\n* Active corneal inflammation or edema\n* Retinal disorders not associated with glaucoma","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Diurnal IOP (as Measured at 8AM and 10AM) Through 3 Months Postoperative","description":"Change from time-matched baseline in IOP at 8AM and 10AM at Day 10, Week 6 and Month 3.\n\nDay 10 8AM IOP minus Baseline 8AM IOP; Day 10 10AM IOP minus Baseline 10AM IOP; Week 6 8AM IOP minus Baseline 8AM IOP; Week 6 10AM IOP minus Baseline 10AM IOP; Month 3 8AM IOP minus Baseline 8AM IOP; Month 3 10AM IOP minus Baseline 10AM IOP.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.26","spread":"0.27"},{"groupId":"OG001","value":"-8.40","spread":"0.27"},{"groupId":"OG002","value":"-7.16","spread":"0.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.20","spread":"0.25"},{"groupId":"OG001","value":"-8.28","spread":"0.25"},{"groupId":"OG002","value":"-7.08","spread":"0.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.83","spread":"0.26"},{"groupId":"OG001","value":"-7.20","spread":"0.26"},{"groupId":"OG002","value":"-7.17","spread":"0.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.92","spread":"0.25"},{"groupId":"OG001","value":"-6.83","spread":"0.25"},{"groupId":"OG002","value":"-7.15","spread":"0.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.29","spread":"0.28"},{"groupId":"OG001","value":"-6.66","spread":"0.27"},{"groupId":"OG002","value":"-6.82","spread":"0.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.21","spread":"0.27"},{"groupId":"OG001","value":"-6.79","spread":"0.27"},{"groupId":"OG002","value":"-6.76","spread":"0.26"}]}]}]},{"type":"SECONDARY","title":"Mean IOP (Control Group vs. Each Implant Group) Through 12 Months Postoperative","description":"Difference in mean IOP, between each test group and the control group, for IOP measurements through the Month 12 follow-up visit","paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":185},"commonTop":["intraocular pressure increased","Iritis"]}}}